Skip to content
stoqly

Plexus Corp

PLXS Nasdaq Printed Circuit Boards Financials FY2016–FY2025

Revenue Total sales reported in the income statement.
$4.0B
1.8% vs prior year
Operating margin Operating income as a share of revenue.
5.0%
0.8 pts
Net income Profit after all expenses, interest and tax.
$173M
54.6%
Free cash flow Cash from operations minus capital spending.
$154M
54.9%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
β€”
Market cap Last close times the latest diluted share count, so it is approximate.
β€”
P/E Last close divided by diluted earnings per share over the last four quarters.
β€”
On $6.78 EPS (TTM)

What Plexus Corp does

No business description yet.

Legal name
PLEXUS CORP
Fiscal year ends
September 27, 2025
Latest annual report
10-K Β· Nov 14, 2025
Accession Β· CIK
0000785786-25-000064
0000785786

Revenue and margins

Plexus Corp had $4.0B of revenue in fiscal 2025, up 1.8% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew 12.1% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $154M in fiscal 2025, 3.8% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Plexus Corp returned $65.3M to shareholders in fiscal 2025, 42% of free cash flow. The diluted share count fell 1.0%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Balance sheet

Cash, debt and the ratios that show how comfortably Plexus Corp can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $270M$275M$256M$345M$306M
Interest coverage 12.4x11.2x6.2x5.8x17.4x
Current ratio 1.7x1.4x1.5x1.5x1.6x
Quick ratio 0.8x0.6x0.6x0.7x0.8x
Total assets $2.5B$3.4B$3.3B$3.2B$3.1B
Total liabilities $1.4B$2.3B$2.1B$1.8B$1.7B
Shareholders' equity $1.0B$1.1B$1.2B$1.3B$1.5B
Net debt (βˆ’ = net cash) β€”β€”β€”β€”β€”

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

β€”

$0.0M

No open-market insider trades in the last 12 months.

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Net income is positive βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“
Cash from operations is positive βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ• βœ“ βœ“ βœ“
Return on assets rose β€” βœ“ βœ• βœ“ βœ• βœ“ βœ• βœ“ βœ• βœ“
Cash from operations exceeds net income βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ• βœ“ βœ“ βœ“
Debt fell relative to assets β€” βœ• βœ“ βœ• β€” β€” β€” β€” β€” β€”
Current ratio rose β€” βœ• βœ“ βœ• βœ• βœ• βœ• βœ“ βœ“ βœ“
Share count didn't rise β€” βœ• βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ“
Gross margin rose β€” βœ“ βœ• βœ• βœ“ βœ“ βœ• βœ“ βœ“ βœ“
Revenue rose relative to assets β€” βœ• βœ“ βœ“ βœ• βœ• βœ• βœ“ βœ• βœ“
F-score β€” / 35 / 97 / 96 / 95 / 86 / 82 / 88 / 86 / 88 / 8
Accruals ratio βˆ’2.9%βˆ’3.2%βˆ’2.8%βˆ’0.3%βˆ’4.3%βˆ’0.2%5.6%βˆ’0.8%βˆ’10.0%βˆ’2.4%
Altman Z'' 6.155.665.815.405.305.273.934.384.745.26

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $2.6B $2.5B $2.9B $3.3B $3.5B $3.5B $3.9B $4.2B $4.0B $4.0B
Gross profit $227M $256M $258M $292M $313M $323M $347M $395M $379M $407M
Operating income $99.4M $130M $118M $142M $153M $176M $178M $196M $168M $202M
Interest expense $14.6M $13.6M $12.2M $12.9M $16.2M $14.3M $15.9M $31.5M $28.9M $11.6M
Pretax income $87.4M $122M $108M $126M $135M $160M $158M $161M $130M $188M
Income tax $11.0M $9.8M $94.6M $17.3M $17.9M $21.5M $20.1M $21.9M $17.7M $15.1M
Net income $76.4M $112M $13.0M $109M $117M $139M $138M $139M $112M $173M
Diluted EPS $2.24 $3.24 $0.38 $3.50 $3.93 $4.76 $4.86 $4.95 $4.01 $6.26
Diluted shares 0.03B 0.03B 0.03B 0.03B 0.03B 0.03B 0.03B 0.03B 0.03B 0.03B
Cash flow
Cash from operations $128M $172M $66.8M $115M $210M $143M βˆ’$26.2M $166M $437M $249M
Capital expenditure $31.1M $38.5M $62.8M $90.6M $50.1M $57.1M $102M $104M $95.2M $95.3M
Free cash flow $96.6M $133M $4.1M $24.7M $160M $85.5M βˆ’$128M $61.8M $341M $154M
Depreciation and amortization $47.4M $45.3M $48.3M $52.2M $56.7M $61.0M $62.7M $69.8M $77.8M $77.8M
Stock-based compensation $19.3M $17.4M $18.0M $21.3M $24.3M $24.8M $23.3M $21.3M $30.3M $30.3M
Acquisitions $0.0M $0.0M $12.4M β€” β€” β€” β€” β€” β€” β€”
Share buybacks $30.0M $34.1M $137M $182M $41.4M $108M $50.4M $40.9M $55.7M $65.3M
Dividends and buybacks $30.0M $34.1M $137M $182M $41.4M $108M $50.4M $40.9M $55.7M $65.3M
Balance sheet
Cash and short-term investments $433M $569M $297M $224M $386M $270M $275M $256M $345M $306M
Total debt $175M $313M $189M $288M β€” β€” β€” β€” β€” β€”
Finance lease liabilities β€” β€” β€” β€” $39.7M $41.5M $44.3M $43.3M $43.5M $44.5M
Current assets $1.4B $1.6B $1.5B $1.5B $1.8B $1.9B $2.8B $2.7B $2.5B $2.4B
Current liabilities $650M $908M $738M $866M $1.0B $1.1B $2.0B $1.8B $1.6B $1.5B
Inventory $564M $655M $794M $701M $763M $972M $1.6B $1.6B $1.3B $1.2B
Property and equipment, net $291M $315M $341M $384M $384M $395M $445M $492M $501M $546M
Intangible assets β€” $0.0M $8.2M β€” β€” β€” β€” β€” β€” β€”
Total assets $1.8B $2.0B $1.9B $2.0B $2.3B $2.5B $3.4B $3.3B $3.2B $3.1B
Total liabilities $849M $950M $1.0B $1.1B $1.3B $1.4B $2.3B $2.1B $1.8B $1.7B
Preferred stock $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Shareholders' equity $917M $1.0B $921M $866M $977M $1.0B $1.1B $1.2B $1.3B $1.5B
Margins
Gross margin 8.9% 10.1% 9.0% 8.9% 8.9% 9.3% 8.8% 9.4% 9.6% 10.1%
Operating margin 3.9% 5.1% 4.1% 4.3% 4.4% 5.1% 4.5% 4.7% 4.2% 5.0%
EBITDA margin 5.7% 6.9% 5.8% 5.9% 6.0% 6.8% 6.1% 6.3% 6.2% 6.9%
Net margin 3.0% 4.4% 0.5% 3.3% 3.4% 4.0% 3.5% 3.3% 2.8% 4.3%
FCF margin 3.8% 5.3% 0.1% 0.7% 4.6% 2.5% βˆ’3.3% 1.5% 8.6% 3.8%
Returns
Return on capital 13.2% 15.5% 9.5% 13.2% β€” β€” β€” β€” β€” β€”
Return on capital employed 8.9% 12.2% 9.9% 12.5% 11.9% 13.2% 12.8% 13.0% 11.1% 12.5%
Return on equity 8.3% 11.5% 1.3% 12.2% 12.7% 13.9% 13.0% 12.0% 8.8% 12.4%
Return on assets 4.3% 6.0% 0.7% 5.5% 5.5% 5.8% 4.7% 4.1% 3.5% 5.5%
Return on tangible equity 8.3% 10.9% 1.4% 12.5% 12.0% 13.5% 12.6% 11.5% 8.4% 11.9%
Growth
Revenue growth β€” βˆ’1.1% 13.7% 14.7% 6.2% βˆ’0.6% 12.8% 7.2% βˆ’5.9% 1.8%
Net income growth β€” 46.6% βˆ’88.4% 732.9% 8.2% 18.2% βˆ’0.5% 0.6% βˆ’19.6% 54.6%
EPS growth β€” 44.6% βˆ’88.3% 821.1% 12.3% 21.1% 2.1% 1.9% βˆ’19.0% 56.1%
FCF growth β€” 37.9% βˆ’97.0% 509.7% 548.9% βˆ’46.7% βˆ’249.6% β€” 452.5% βˆ’54.9%
Share count change β€” 1.3% βˆ’1.8% βˆ’8.4% βˆ’3.7% βˆ’2.5% βˆ’2.5% βˆ’1.1% βˆ’0.7% βˆ’1.0%
Financial health
Net debt / EBITDA βˆ’1.8x βˆ’1.5x βˆ’0.7x 0.3x β€” β€” β€” β€” β€” β€”
Debt / equity 0.2x 0.3x 0.2x 0.3x β€” β€” β€” β€” β€” β€”
Interest coverage 6.8x 9.6x 9.7x 11.1x 9.5x 12.4x 11.2x 6.2x 5.8x 17.4x
Current ratio 2.2x 1.8x 2.1x 1.8x 1.8x 1.7x 1.4x 1.5x 1.5x 1.6x
Quick ratio 1.3x 1.1x 1.0x 1.0x 1.0x 0.8x 0.6x 0.6x 0.7x 0.8x
Capital allocation
Capex / revenue 1.2% 1.5% 2.2% 2.7% 1.4% 1.6% 2.6% 2.5% 2.4% 2.4%
Stock comp / revenue 0.8% 0.7% 0.6% 0.6% 0.7% 0.7% 0.6% 0.5% 0.8% 0.8%
Payouts / FCF 31.1% 25.6% 3,382.7% 737.3% 25.8% 126.9% β€” 66.3% 16.3% 42.4%
Quality scores
Piotroski F-score β€” 5.0 7.0 6.0 5.0 6.0 2.0 8.0 6.0 8.0
Altman Z'' 6.2 5.7 5.8 5.4 5.3 5.3 3.9 4.4 4.7 5.3
Accruals ratio βˆ’2.9% βˆ’3.2% βˆ’2.8% βˆ’0.3% βˆ’4.3% βˆ’0.2% 5.6% βˆ’0.8% βˆ’10.0% βˆ’2.4%

Source: SEC EDGAR XBRL filings (CIK 0000785786). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open